Mercer Global Advisors’s Treace Medical Concepts TMCI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$179K Buy
45,006
+15,950
+55% +$43.8K ﹤0.01% 3291
2026
Q1
$38.9K Buy
29,056
+18,806
+183% +$37.5K ﹤0.01% 3150
2025
Q4
$25.1K Sell
10,250
-2,666
-21% -$11.6K ﹤0.01% 2816
2025
Q3
$86.7K Buy
+12,916
New +$84.3K ﹤0.01% 2540

Other funds holding TMCI

Mercer Global Advisors's TMCI Position: Q2 2026 in Review

Mercer Global Advisors increased its Treace Medical Concepts (TMCI) stake by 55% in Q2 2026, buying an estimated $43.8K and bringing the position to 45,006 shares worth $179K. The position accounts for ﹤0.01% of the portfolio, ranked #3291.

Mercer Global Advisors first reported a position in TMCI in Q3 2025 and has held it in 4 quarters since. 116 funds tracked by Wall St. Rank hold TMCI as of Q2 2026.

  • Mercer Global Advisors held 45,006 shares of Treace Medical Concepts worth $179K as of Q2 2026.
  • Mercer Global Advisors bought 15,950 Treace Medical Concepts shares in Q2 2026, an estimated $43.8K.
  • Treace Medical Concepts made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #3291 holding.
  • Mercer Global Advisors first reported a position in Treace Medical Concepts in Q3 2025 and has held it in 4 quarters since.
  • 116 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.